Sandbox 111: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 187: | Line 187: | ||
---- | ---- | ||
'''''1.1 Class''''' | '''''1.1 Class''''' | ||
| Line 199: | Line 198: | ||
'''''1.2 Indications''''' | '''''1.2 Indications''''' | ||
: 1.2.1 Go to the Dailymed, find the content in chapter "INDICATIONS AND USAGE", copy the indications you find and paste it on the edit box. | : 1.2.1 Go to the Dailymed, find the content in chapter "INDICATIONS AND USAGE", copy the indications you find and paste it on the edit box. | ||
| Line 212: | Line 209: | ||
::1.2.2.2 Example 2: The content of chapter "INDICATIONS AND USAGE" of conivaptan is: Vaprisol is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia. | ::1.2.2.2 Example 2: The content of chapter "INDICATIONS AND USAGE" of conivaptan is: Vaprisol is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia. | ||
It's not compatible to the form so it should be reorganized into "euvolemic and hypervolemic hyponatremia in hospitalized patients" | It's not compatible to the form so it should be reorganized into "euvolemic and hypervolemic hyponatremia in hospitalized patients" | ||
---- | |||
'''''1.3 Common Adverse Reactions''''' | |||
: 1.3.1 Go to the Micromedex, copy the content of chapter "common adverse effect".Reorganize it by removing the numbers and organs'system. | |||
: 1.3.2 Example 1: The content in Micromedex is Cardiovascular: Hypertension (20 mg/day, 8%; 40 mg/day, 6% ), Orthostatic hypotension (20 mg/day, 14%; 40 mg/day, 6% ), Peripheral edema (20 mg/day, 3%; 40 mg/day, 8% ), Phlebitis (20 mg/day, 51%; 40 mg/day, 32% ) | |||
Dermatologic: Injection site reaction (20 mg/day, 73%; 40 mg/day, 63% ) | |||
Endocrine metabolic: Hypokalemia (20 mg/day, 22%; 40 mg/day, 10% ), Increased thirst (20 mg/day, 3%; 40 mg/day, 6% ) | |||
Gastrointestinal: Constipation (20 mg/day, 8%; 40 mg/day, 6% ), Diarrhea (40 mg/day, 7% ), Vomiting (20 mg/day, 5%; 40 mg/day, 7% ) | |||
Neurologic: Headache (20 mg/day, 8%; 40 mg/day, 10% ) | |||
Renal: Increased frequency of urination (6% ), Polyuria (4.9% ) | |||
Other: Fever (20 mg/day, 11%; 40 mg/day, 5% ) | |||
What you should enter is hypertension, orthostatic hypotension, peripheral edema, phlebitis, injection site reaction, hypokalemia, increased thirst, constipation, diarrhea, vomiting, headache, increased frequency of urination, polyuria, fever. | |||
---- | ---- | ||
| Line 224: | Line 237: | ||
|} | |} | ||
---- | |||
<BIG><BIG>'''''1. HOW TO EDIT THE BLACKBOX WARNING'''''</BIG></BIG> | |||
---- | |||
'''''1.1 Title''''' | |||
: You should add <span style="color:#FF0000;"> before the title and </span> after the title. | |||
---- | |||
=Adult Indications and Dosage= | =Adult Indications and Dosage= | ||
{| | {| | ||
Revision as of 18:09, 30 April 2014